Palmitoylethanolamide and luteolin vs no intervention
Recovery of sense of smell (as · adults with olfactory dysfunction for ≥ 4 weeks following COVID‐19 infection
It is very uncertain whether palmitoylethanolamide and luteolin changes recovery of sense of smell (as compared with no intervention (very low certainty).
1 finding from 1 review
- Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes onlyRR 0.24 [0.03, 1.67]1 study · 12 participantsVery low